Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Director | May 20, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,458 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 22,458 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F3: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000072 · wk-form4_1779480278.xml · derivative · entry 3 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3 · derivative.exercise_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. F3 · derivative.expiration_date: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000072 · wk-form4_1779480278.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 10,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-26-000072 · wk-form4_1779480278.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,220 Underlying: Common Stock · 10,220 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. F2 · derivative.expiration_date: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000141 · wk-form4_1750277283.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:08 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000141 · wk-form4_1750277283.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000107 · wk-form4_1748030616.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,387 | $20.64 | $90,547.68 |
DisclosureSEC source: 0001438133-25-000107 · wk-form4_1748030616.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 8,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-25-000107 · wk-form4_1748030616.xml · derivative · entry 3 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,759 Underlying: Common Stock · 8,759 shares Expires not disclosed F4 · security: Awarded on May 21, 2025 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 1,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,749 | $45.33 | $79,282.17 |
DisclosureSEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 4,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000127 · wk-form4_1716592978.xml · derivative · entry 3 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,065 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Awarded on May 24, 2023 pursuant to the 2023 Plan. F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,065 | $51.73 | $210,282.45 |
DisclosureSEC source: 0001438133-24-000127 · wk-form4_1716592978.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 24, 2024 23:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 4,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000127 · wk-form4_1716592978.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,387 Underlying: Common Stock · 4,387 shares Expires not disclosed F1 · security: Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000141 · wk-form4_1686945946.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,498 Underlying: Common Stock · 1,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 20:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000141 · wk-form4_1686945946.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2023 Filed May 26, 2023 20:06 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRSU 2023 05 24 · Derivative | 4,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000105 · wf-form4_168513156337246.xml · derivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,065 Underlying: Common Stock · 4,065 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on May 24, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:46 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 5,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000167 · wf-form4_165550599505977.xml · derivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,247 Underlying: Common Stock · 5,247 shares Expires not disclosed F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.